Khalid Khalaf Alharbi

Prof. Dr. Khalid Khalaf Alharbi

Clinical Laboratory sciences, King Saud University, Riyadh, Ar Riyāḑ, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Saudi Journal of Biological Sciences
Verified
Journal Article
Open access
Khalid Khalaf AlharbiKhalid Khalaf Alharbi
Khalid Khalaf Alharbi
YAYazeed A. Al-Sheikh
Yazeed A. Al-Sheikh
Nanodiagnostics is the term used for the application of nanobiotechnology in molecular diagnosis, which is important for developing personalized cancer therapy. It is usually based on pharmacogenetics, pharmacogenomics, and pharmacoproteomic information but also takes into consideration environmental factors that influence response to therapy. Nanotechnology in medicine involves applications of nanoparticles currently under development, as well as longer range research that involves the use of manufactured nano-robots to make repairs at the cellular level. Nanodiagnostic technologies are also being used to refine the discovery of biomarkers, as nanoparticles offer advantages of high volume/surface ratio and multifunctionality. Biomarkers are important basic components of personalized medicine and are applicable to the management of cancer as well. The field of nano diagnostics raises certain ethical concerns related with the testing of blood. With advances in diagnostic technologies, doctors will be able to give patients complete health checks quickly and routinely. If any medication is required this will be tailored specifically to the individual based on their genetic makeup, thus preventing unwanted side-effects.

AAAmal F. Alshammary
Amal F. Alshammary
Khalid Khalaf AlharbiKhalid Khalaf Alharbi
Khalid Khalaf Alharbi
NANaif Jameel Alshehri
Naif Jameel Alshehri
Vishal Vennu, MSc., Ph.D.Vishal Vennu, MSc., Ph.D.
Vishal Vennu, MSc., Ph.D.
Imran Ali KhanImran Ali Khan
Imran Ali Khan
Although numerous studies have described the link between metabolic syndrome (MetS) and Coronary Artery Disease (CAD), no meta-analysis has been carried out on this relationship. Thus, the present study intended to address this limitation. A systematic search was carried out using electronic databases, such as PubMed, CINAHL Plus, Medline, and Web of Science. A sum of 10 studies (n = 9327) was incorporated in the meta-analysis. Compared with non-MetS, MetS was significantly associated with high CAD risk (OR = 4.03, 95% CI = 3.56–4.56). The MetS components were also significantly correlated with high CAD risk (OR = 3.72, 95% CI = 3.22–4.40). The presence of two (OR = 3.93, 95% CI = 2.81–5.49), three (OR = 4.09, 95% CI = 2.85–5.86), four (OR = 4.04, 95% CI = 2.83–5.78), or all five MetS components (OR = 3.92, 95% CI = 3.11–4.93), were significantly associated with a high risk of CAD. MetS and its individual or combined elements were linked with high CAD risk based on contemporary evidence. Thus, the assessment of MetS and its components might help identify people at a higher risk of advancing CAD in the future.

24 October 2015 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
Khalid Khalaf AlharbiKhalid Khalaf Alharbi
Khalid Khalaf Alharbi
Imran Ali KhanImran Ali Khan
Imran Ali Khan
RSRabbani Syed
Rabbani Syed
FAFawiziah Khalaf Alharbi
Fawiziah Khalaf Alharbi
AMAbdul Khader Mohammed
Abdul Khader Mohammed
Nasser M Al-DaghriNasser M Al-Daghri
Nasser M Al-Daghri
Type 2 diabetes mellitus (T2DM) is a chronic and multifactorial disease with a rapidly rising incidence in Saudi Arabia. Various genes including zinc finger protein 1 (JAZF1) and tetraspanin 8/leucine-rich repeat-containing G protein-coupled receptor (TSPAN8/LGR5) have been previously described to be associated with T2DM. This study investigated the association of JAZF1 (rs864745) and TSPAN8 (rs7961581) with T2DM in a Saudi population. Genomic DNA samples from 400 Saudi T2DM patients and 400 healthy controls were genotyped and analyzed using a polymerase chain reaction-restriction fragment length polymorphism method. The difference between the genotype frequencies were carried out with Chi-square test. Odds ratio, 95 % confidence intervals and p values were calculated using multinomial logistic regression. Dominant and recessive models were implemented to show the statistical significances. Analysis of variance was used to compare differences between genotypes for the various parameters. Distribution frequencies of the AA, AG, and GG genotypes of JAZF1 (rs864745) differed significantly among T2DM patients and healthy controls (p < 0.05). The AG and GG genotypes were independently and significantly associated with a T2DM risk after adjusting for factors such as age, sex, and body mass index [odds ratio (OR) 2.1 (95 % confidence interval (CI) 1.3–3.4); p = 0.002] and [OR 1.9 (95 % CI 1.2–3.1); p = 0.005], respectively. A genotype-based stratification of anthropometric and biochemical data revealed that the AG + GG genotype is associated with waist circumference (p = 0.04) and fasting blood glucose (p = 0.01) and high-density lipoprotein cholesterol levels (p = 0.02). None of the allele or genotype showed the significant association between the T2DM cases and control subjects in rs7961581 polymorphism in TSPAN8/LGR5 gene. The rs864745 variant in JAZF1 gene may act as genetic risk factors for the development of T2DM in a Saudi population.

26 November 2013 in Journal of Biosciences
Verified
Journal Article
Closed access
PDF file
Khalid Khalaf AlharbiKhalid Khalaf Alharbi
Khalid Khalaf Alharbi
Imran Ali KhanImran Ali Khan
Imran Ali Khan
Nasser M Al-DaghriNasser M Al-Daghri
Nasser M Al-Daghri
AMAnjana Munshi
Anjana Munshi
VSVandana Sharma
Vandana Sharma
RSRabbani Syed
Rabbani Syed

2 March 2012 in Annals of Human Genetics
Verified
Journal Article
Open access
PDF file
Muslim Mohammed Salamah Al SaadiMuslim Mohammed Salamah Al Saadi
Muslim Mohammed Salamah Al Saadi
TGTom R. Gaunt
Tom R. Gaunt
CBChristopher R. Boustred
Christopher R. Boustred
PGPhilip A. I. Guthrie
Philip A. I. Guthrie
XLXuan Liu
Xuan Liu
IDIan N. M. Day
Ian N. M. Day
Summary: Primary ciliary dyskinesia (PCD) is a genetic disorder, usually autosomal recessive, causing early respiratory disease and later subfertility. Whole exome sequencing may enable efficient analysis for locus heterogeneous disorders such as PCD. We whole‐exome‐sequenced one consanguineous Saudi Arabian with clinically diagnosed PCD and normal laterality, to attempt ab initio molecular diagnosis.We reviewed 13 known PCD genes and potentially autozygous regions (extended homozygosity) for homozygous exon deletions, non‐dbSNP codon, splice‐site base variants or small indels. Homozygous non‐dbSNP changes were also reviewed exome‐wide. One single molecular read representing RSPH9 p.Lys268del was observed, with no wild‐type reads, and a notable deficiency of mapped reads at this location. Among all observations, RSPH9 was the strongest candidate for causality. Searching unmapped reads revealed seven more mutant reads. Direct assay for p.Lys268del (MboII digest) confirmed homozygosity in the affected individual, then confirmed homozygosity in three siblings with bronchiectasis. Our finding in southwest Saudi Arabia indicates that p.Lys268del, previously observed in two Bedouin families (Israel, UAE), is geographically widespread in the Arabian Peninsula. Analogous with cystic fibrosis CFTR p.Phe508del, screening for RSPH9 p.Lys268del (which lacks sentinel dextrocardia) in those at risk would help in early diagnosis, tailored clinical management, genetic counselling and primary prevention.

1 April 2014 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
Khalid Khalaf AlharbiKhalid Khalaf Alharbi
Khalid Khalaf Alharbi
Imran Ali KhanImran Ali Khan
Imran Ali Khan
MBMohammad D Bazzi
Mohammad D Bazzi
Nasser M Al-DaghriNasser M Al-Daghri
Nasser M Al-Daghri
THTarique N Hasan
Tarique N Hasan
Mourad A. M. Aboul-SoudMourad A. M. Aboul-Soud
Mourad A. M. Aboul-Soud
Fatty acid-binding protein 2 (FABP2) is an intracellular protein expressed exclusively in the enterocytes of proximal small intestine. FABP2 has a high affinity for saturated and unsaturated long-chain fatty acids and is believed to be involved in the absorption and transport of dietary fatty acids. This is a case–control study conceded in 438 T2DM cases and 460 subjects with normal glucose levels and non-obese considered as healthy controls. Allelic discrimination was performed using TaqMan single-nucleotide polymorphism was carried out by real time-polymerase chain reaction (RT-PCR) assays using purified DNA. Clinical data and anthropometric measurements except age, glucose levels and lipid profile of the patients were significantly different from those of the controls (p < 0.05). Statistical analyses failed to show any type of significant association of the polymorphism between cases and controls. However logistic regression analyses was suggests that the TT genotype is significantly associated with male patients (p = 0.001). None of the allele or genotypes of FABP2 A54T was associated with T2DM cases versus the controls (AT genotype, OR = 0.85 (0.64-1.12), p = 0.25; TT genotype, OR = 0.66 (0.39-1.11), p = 0.11; T allele, 0.82 (0.67-1.02), p = 0.08). In conclusion, this study suggests that the above named variant in FABP2 gene is not potential contributor to the risk of T2DM and related traits in a Saudi population. However TT genotype is a risk factor for the disease in males.